ClinicalTrials.gov
public full text
Public Domain
Effect and Prognosis of Immunohistochemical Biomarkers Changes in Patients With Bladder Cancer After Neoadjuvant Chemotherapy
Clinical trial to investigate the relationship between the expression of immunohistochemical biomarkers GATA-3, CK20, P53 and Ki67 in bladder cancer and pathological complete response after neoadjuvant chemotherapy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Immunohistochemical Expression of Novel Therapeutic Targets in Squamous Cell Carcinoma of the Bladder.#402576
- Risk of Bladder Cancer in Type 2 Diabetes Patients With Pioglitazone Therapy "PROBE"#184813
- WEE1 kinase inhibition to overcome acquired resistance to targeted therapies in colorectal cancer#480447
- WEE1 kinase inhibition to overcome acquired resistance to targeted therapies in colorectal cancer.#285055
- Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanoma#14284
Record · ID 834973
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive